International Cannabis Weekly: 456

SWITZERLAND LAUNCHES EIGHT CANNABIS PILOT WITH FIRST-EVER HOME DELIVERY MODEL FOR PARTICIPANTS

Switzerland has granted approval for a new five-year, 5000-participant adult-use cannabis pilot trial, marking the eighth since the groundbreaking project began in 2023.

READ MORE  »

IRELAND’S CROSS-PARTY DRUGS COMMITTEE CALLS FOR FULL DECRIMINALISATION

READ MORE »

DEA OPENS RESCHEDULING HEARING WITH SCIENCE-BASED SUPPORT FOR ITS OWN RULE

READ MORE »

• UK medical cannabis market expected to surpass 140,000 patients during 2026 growth surge.
• Pharmacists account for nine of the UK’s ten highest prescribing medical cannabis clinicians.
• Village Farms launches limited-edition pre-roll duo pack through Netherlands recreational cannabis market.
• Malta records Europe’s lowest cannabis use rates among young people, new figures reveal.
• War in Ukraine continues to shape the future of the country’s flagship hemp producer.
• France submits the long-awaited decree on the reimbursement of medical cannabis to the Council of State.

LEARN MORE »

• Georgia expands medical cannabis programme as new state laws officially take effect.
• DEA begins historic hearings on the proposal to federally reschedule cannabis in the United States.
• Massachusetts cannabis advocates rally to oppose efforts aimed at repealing legalisation measures.
• Virginia approves recreational cannabis retail sales framework with market launch planned for 2027.
• Glass House shares come under scrutiny as investors assess the cannabis producer’s outlook.
• MariMed submits DEA registration applications to expand federally authorised cannabis research activities.
• California commits $227 million to intensify enforcement against illicit cannabis cultivation and sales.
• Connecticut governor and Mashantucket tribe push forward updated cannabis compact for Foxwoods operations.

• Tilray Brands agrees to acquire digital healthcare platform HelloMD to expand patient services.
• Canadian cannabis producers now supply the majority of the United Kingdom’s medical market.
• Health Canada responds to concerns over oversight and regulation of retail cannabis stores.
• Cannabis investment no longer relies on hype as Canada’s next wave of businesses look to the markets.
• Entourage Health enters creditor protection as it begins cannabis business wind-down and sale process.
• Canadian cannabis companies showcase products and innovations at Mary Jane Berlin 2026 exhibition.

• Cannabis use continues to rise in Brazil with increasing consumption among female adolescents.
• Colombia’s justice ministry leads workshop on regulating medical, scientific and industrial cannabis sectors.
• Veterinarian Francisca Medina explains how cannabis became the focus of her scientific career.
• Mexico’s Supreme Court upholds collective cannabis self-consumption permit issued by COFEPRIS.

• Australia’s updated medical cannabis driving laws welcomed despite calls for stronger legal safeguards.
• Thailand introduces tougher penalties for cannabis-related offences under revised regulatory framework.
• Thailand launches new digital platform designed to accelerate cannabis export approvals and trade.
• CCA says no update on THC rescheduling as reform work continues.

• Israel opens new investigation into imports of Canadian medical cannabis products and supply chains.
• Grey list removed means Jersey can pull investment money out of South African cannabis.